| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000012309 |
| Receipt No. | R000014394 |
| Official scientific title of the study | Continuous blood glucose monitoring by artificial pancreas during interventional radiology |
| Date of disclosure of the study information | 2013/11/18 |
| Last modified on | 2017/02/10 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Continuous blood glucose monitoring by artificial pancreas during interventional radiology | |
| Title of the study (Brief title) | Blood Glucose Monitoring by Artificial Pancreas -InterVentional Radiology (GMAP-IVR) | |
| Region |
|
|
| Condition | ||
| Condition | Patients treated intra- and extracranial diseases (aneurysms, arterial stenosis, and tumors, etc.)with interventional radiology | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study evaluates that continuous blood glucose monitoring by artificial pancreas detects adverse events during interventional radiology by blood glucose change. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Correlation between blood glucose change and adverse event during IVR |
| Key secondary outcomes | Correlation between hypreintense lesions on postoperative diffusion weighted images and blood glucose change
Correlation between change of cerebral blood flow on postoperative SPECT and blood glucose change Incidence of unmeasurable events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | During IVR, blood glucose is continuously monitored by artificial pancreas. Blood is sampled at a 2mL/hr from peripheral vein. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Diseases required IVR
Men and women of 20 years of age or older Unnecessary of insulin treatment Written Informed consent |
|||
| Key exclusion criteria | Necessary of insulin treatment
Requirement of glucose administration before and during surgery Pregnant or lactating women and women of child bearing potential Patients judged by investigators ineligible for participation as study subjects for any other reason. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Shin-Ichi Miyatake |
| Organization | Osaka Medical College |
| Division name | Neurosurgery |
| Address | 2-7, Daigakumachi, Takatsuki, Osaka, 569-8686, Japan |
| TEL | 072-683-1221 |
| neu070@poh.osaka-med.ac.jp | |
| Public contact | |
| Name of contact person | Motomasa Furuse |
| Organization | Osaka Medical College |
| Division name | Neurosurgery |
| Address | 2-7, Daigakumachi, Takatsuki, Osaka, 569-8686, Japan |
| TEL | 072-683-1221 |
| Homepage URL | |
| neu054@poh.osaka-med.ac.jp | |
| Sponsor | |
| Institute | Osaka Medical College |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Neurosurgery, Osaka Medical College |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014394 |